Note about Credits
PHQ9 is ©Pfizer.
May only be reprinted with permission, courtesy of Pfizer Limited."
PRIME-MD ® is a trademark of Pfizer.
Further reading & references
- Kroenke K, Spitzer RL, Williams JB; The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.
- Dietrich AJ, Oxman TE, Burns MR, et al; Application of a depression management office system in community practice: a demonstration. J Am Board Fam Pract. 2003 Mar-Apr;16(2):107-14.
- Use of the PHQ-9 to make a tentative diagnosis of depression; The Macarthur Initiative on Depression in Primary Care Website.
- Pinto-Meza A, Serrano-Blanco A, Penarrubia MT, et al; Assessing depression in primary care with the PHQ-9: can it be carried out over the telephone? J Gen Intern Med. 2005 Aug;20(8):738-42.
|Original Author: Dr Tim Kenny||Current Version: Dr Tim Kenny||Peer Reviewer: Hilary Cole|
|Last Checked: 09/11/2010||Document ID: 2582 Version: 27||© EMIS|
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.